<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT932-1519</title>
	</head>
	<body>
		<main>
			<p>930623 FT  23 JUN 93 / UK Company News: Tepnel Diagnostics losses at Pounds 507,000 In its first six months since flotation, Tepnel Diagnostics, the USM-quoted biotechnology company, incurred pre-tax losses of Pounds 507,000 compared with Pounds 144,000. Sir David Trippier, chairman, said that progress had been seen in product development, achieved within budgeted costs. For the half year to March 31 there were operating losses of Pounds 660,000, which comprised administrative expenses of Pounds 328,000 (Pounds 32,000) and research and development costs of Pounds 332,000 (Pounds 112,000). Losses per share amounted to 2.21p. There is no dividend.</p>
		</main>
</body></html>
            